Skip to main content

Clinical Laboratory Services Market Size [2023-2030] | Industry Share, Revenue, Key Players, CAGR, Demand and Forecast

Companies Profiled in the Clinical Laboratory Services Market Are Clinical Laboratory Services, Inc., Covance Inc., Fresenius Medical Care AG & Co. KGaA, NeoGenomics Laboratories, Inc., Mayo Foundation for Medical Education and Research, SYNLAB International GmbH, Sonic Healthcare, BioReference Laboratories, UNILABS, Laboratory Corporation of America Holdings, Novartis AG.

Pune, India, March 03, 2023 (GLOBE NEWSWIRE) — The global Clinical Laboratory Services Market is categorized based on laboratory type, ownership, end user, and geography in the report. The market is divided into integrated clinical laboratories and specialty clinical laboratories under the laboratory type, with the latter holding a significant share of the global clinical laboratory services market. The report predicts that the specialty clinical laboratory will maintain its position in the future, owing to an increase in the number of patients and a growing focus on preventing viral diseases.


Get a Free Sample Research PDF Brochure:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/clinical-laboratory-services-market-100725


Report Scope of Clinical Laboratory Services Market:

Report CoverageDetails
Forecast Period2023 to 2030
Base Year2022
Historical Data for2019 to 2021


Key Takeaways from the Clinical Laboratory Services Market:

  • The growth of the market is significantly driven by the increasing prevalence of chronic diseases such as obesity, diabetes, and cardiovascular diseases.
  • Due to an aging population, North America dominated the global clinical laboratory services market in 2017.
  • The growth of the market is impeded by the lack of healthcare infrastructure, including laboratory analysts, as well as stringent regulations imposed on the development.

Drivers & Restraints:

The market is expected to receive a boost from increased awareness of periodic health checkups.

the rising prevalence of epidemic diseases worldwide contributes to the surge in demand for clinical laboratory services, thereby driving the global market. The market is segmented into standalone clinical laboratories, hospital-owned clinical laboratories, and others based on ownership, and into research centers, clinics, hospitals, and others based on the end user.


Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/clinical-laboratory-services-market-100725


Segments:

Clinical Laboratory Services Market SegmentationsBy Laboratory Type

  • Integrated Clinical Laboratory
  • Specialty Clinical Laboratory
By End User

  • Clinics
  • Research Centers
  • Hospitals
By Ownership

  • Standalone clinical laboratory
  • Hospital-owned clinical laboratory


Pre-Book Research Report:

https://www.fortunebusinessinsights.com/checkout-page/100725


REGIONAL INSIGHTS

The growth in Asia Pacific and the Middle East and Africa is expected to receive a boost from increasing awareness campaigns regarding advanced clinical technologies.

Cost control trends among hospitals, technological advancements, and increasing demand for diagnostics have recently started to propel the global clinical laboratory services market in North America. According to Fortune Business Insights, the Middle East and Africa, as well as Asia Pacific, have significant growth potential during the forecast period in the global clinical laboratory services market due to an increase in the usage of advanced clinical technology services and rising awareness regarding disease prevention.

Competitive Landscape

Strategic investments are being made by key players such as SRL Diagnostics and Carlyle Group to boost sales.

In February 2019, SRL Diagnostics, a diagnostic company headquartered in Gurugram, India, announced the opening of its largest accredited lab network in Tirupati. The lab will offer services to approximately 3 crore pilgrims who visit Tirupati, as it is considered one of India’s holiest pilgrimage sites. In October 2018, Carlyle Group, a multinational private equity firm based in the U.S., and Meinian Onehealth Healthcare Holdings Co., a renowned provider of health checkup and medical treatment based in China, made strategic investments in Adicon Holding Ltd., an independent clinical laboratory, and became a single shareholder.

List of Key Players Profiled in the Global Clinical Laboratory Services Market:

  • Clinical Laboratory Services Inc.
  • Covance Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • NeoGenomics Laboratories Inc.
  • Mayo Foundation for Medical Education and Research
  • SYNLAB International GmbH
  • Sonic Healthcare
  • BioReference Laboratories
  • UNILABS
  • Laboratory Corporation of America Holdings
  • Novartis AG
  • Adicon Holding Limited


Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/queries/clinical-laboratory-services-market-100725


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

FAQ:

What are the clinical laboratory services?

Clinical laboratories play a crucial role in the healthcare industry by providing services that aid in the diagnosis and treatment of diseases which include pathology services, urinalysis, immunology & allergy testing, cholesterol testing and others

Address:

Fortune Business Insights Pvt. Ltd.9th Floor, Icon Tower, Baner –

Mahalunge Road, Baner, Pune-411045,

Maharashtra, India.

Phone:

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.